Can digital adherence technologies reduce inequity in tuberculosis treatment success? Evidence from a randomised controlled trial

Can digital adherence technologies reduce inequity in tuberculosis treatment success? Evidence from a randomised controlled trial

Introduction Tuberculosis (TB) is a global health emergency and low treatment adherence among patients is a major barrier to ending the TB epidemic. The WHO promotes digital adherence technologies (DATs) as facilitators for improving treatment adherence in resource-limited settings. However, limited...

Full description

Bibliographic Details
Main Authors: Philip Owiti, Ramnath Subbaraman, Justin J Boutilier, Erez Yoeli, Jon Rathauser, Jónas Oddur Jónasson
Format: Article
Language:English
Published: BMJ Publishing Group 2022-12-01
Series:BMJ Global Health
Online Access:https://gh.bmj.com/content/7/12/e010512.full

Internet

https://gh.bmj.com/content/7/12/e010512.full

Similar Items